immatics biotechnologies GmbH (NASDAQ:IMTXW – Get Rating)'s stock price traded down 27.1% on Friday . The stock traded as low as $1.67 and last traded at $1.67. 378 shares changed hands during trading, a decline of 97% from the average session volume of 13,991 shares. The stock had previously closed at $2.29.
immatics biotechnologies Stock Down 27.1 %
The stock's fifty day simple moving average is $2.11.
Institutional Investors Weigh In On immatics biotechnologies
A number of large investors have recently modified their holdings of the business. Virtu Financial LLC purchased a new stake in immatics biotechnologies in the fourth quarter valued at approximately $28,000. Jefferies Financial Group Inc. acquired a new position in shares of immatics biotechnologies during the 4th quarter worth approximately $80,000. Alyeska Investment Group L.P. acquired a new position in shares of immatics biotechnologies during the 4th quarter worth approximately $529,000. Finally, Aristeia Capital LLC raised its stake in shares of immatics biotechnologies by 3,293.6% during the 4th quarter. Aristeia Capital LLC now owns 754,590 shares of the company's stock worth $1,856,000 after buying an additional 732,354 shares during the period.
Featured Stories
- Get a free copy of the StockNews.com research report on immatics biotechnologies (IMTXW)
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
Receive News & Ratings for immatics biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for immatics biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
納斯達克交易代碼:IMTXW-GET Rating)週五股價下跌27.1%。該股最低跌至1.67美元,最新報1.67美元。378股股票在交易中易手,較13,991股的平均成交量下跌97%。該股此前收盤報2.29美元。
免疫生物技術類股下跌27.1%
該股的50日簡單移動均線切入位為2.11美元。
機構投資者對免疫生物技術發表看法
一些大型投資者最近調整了對該公司的持股。Virtu Financial LLC在第四季度購買了Immatics BioTechnologies的新股份,價值約2.8萬美元。傑富瑞金融集團在第四季度收購了價值約8萬美元的免疫生物技術公司股票。Alyeska Investment Group L.P.在第四季度收購了免疫生物技術公司的新股票,價值約52.9萬美元。最後,Aristeia Capital LLC在第四季度將其在免疫生物技術公司的股份增加了3,293.6%。Aristeia Capital LLC現在持有該公司754,590股股票,價值1,856,000美元,在此期間又購買了732,354股。
專題報道
- 免費獲取StockNews.com關於免疫生物技術的研究報告(IMTXW)
- 2個近海鑽探公司將大賺一筆
- 未來有望實現兩位數上漲的三隻史泰博股票
- 投資者能信任消費者來提升美國戶外品牌嗎?
- 如何購買高收益股利股票
- 甲骨文已表示:股價下跌5%
獲得《免疫生物技術日報》新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收最新新聞和分析師對immatics生物技術及相關公司的評級的每日摘要。